Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 5/20 | 0.39 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.37 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.37 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 3/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | QRFPR | Q96P65 | 1/20 | 0.35 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.34 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29876444 | 1.00 | MME (0.39) | MMEPRMT1OPRM1OPRD1PDCD1LG2 | |
| SCHEMBL29473532 | 1.00 | MME (0.39) | MMEPRMT1OPRM1OPRD1PDCD1LG2 | |
| SCHEMBL31121552 | 1.00 | MME (0.39) | MMEPRMT1OPRM1OPRD1PDCD1LG2 | |
| SCHEMBL30593912 | 0.90 | OPRM1 (0.43) | MMEPRMT1OPRM1OPRD1PDCD1LG2 | |
| SCHEMBL31031477 | 0.85 | ALDH1A1 (0.41) | MMETERT | |
| SCHEMBL6749006 | 0.85 | TGFBR1 (0.42) | MMEOPRM1OPRD1TGFBR1QRFPR | |
| SCHEMBL31187165 | 0.85 | TGFBR1 (0.42) | MMEOPRM1OPRD1TGFBR1QRFPR | |
| SCHEMBL17874144 | 0.85 | TGFBR1 (0.42) | MMEOPRM1OPRD1TGFBR1QRFPR | |
| SCHEMBL6749004 | 0.85 | TGFBR1 (0.42) | MMEOPRM1OPRD1TGFBR1QRFPR | |
| SCHEMBL1635449 | 0.85 | TGFBR1 (0.42) | MMEOPRM1OPRD1TGFBR1QRFPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4313083-A1 | MULTIFUNCTIONAL IMMUNE CELL THERAPIES | Arcellx, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022204340-A1 | MULTIFUNCTIONAL IMMUNE CELL THERAPIES | ARCELLX, INC. (US) | 2022-09-29 | — | — | WO | disclosed |